Carlsmed, Inc.
CARL
$13.74
$0.141.03%
NASDAQ
06/30/2025 | 06/30/2024 | ||||
---|---|---|---|---|---|
Net Income | -18.10% | -15.24% | |||
Total Depreciation and Amortization | 52.50% | -12.50% | |||
Total Amortization of Deferred Charges | -- | -- | |||
Total Other Non-Cash Items | 109.39% | -13.02% | |||
Change in Net Operating Assets | 41.91% | 78.93% | |||
Cash from Operations | 13.65% | 15.42% | |||
Capital Expenditure | -293.98% | 66.00% | |||
Sale of Property, Plant, and Equipment | -- | -- | |||
Cash Acquisitions | -- | -- | |||
Divestitures | -- | -- | |||
Other Investing Activities | -122.58% | -- | |||
Cash from Investing | -182.35% | 66.00% | |||
Total Debt Issued | -- | -- | |||
Total Debt Repaid | -- | -- | |||
Issuance of Common Stock | -77.18% | -8.33% | |||
Repurchase of Common Stock | -- | -- | |||
Issuance of Preferred Stock | -100.00% | -- | |||
Repurchase of Preferred Stock | -- | -- | |||
Total Dividends Paid | -- | -- | |||
Other Financing Activities | -519.57% | 200.00% | |||
Cash from Financing | -119.20% | -84.08% | |||
Foreign Exchange rate Adjustments | -- | -- | |||
Miscellaneous Cash Flow Adjustments | -- | -- | |||
Net Change in Cash | -401.18% | -100.51% | |||